Kevin D. Foust

10.9k total citations · 3 hit papers
47 papers, 5.4k citations indexed

About

Kevin D. Foust is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Kevin D. Foust has authored 47 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 29 papers in Genetics and 21 papers in Genetics. Recurrent topics in Kevin D. Foust's work include Neurogenetic and Muscular Disorders Research (29 papers), Virus-based gene therapy research (17 papers) and RNA modifications and cancer (10 papers). Kevin D. Foust is often cited by papers focused on Neurogenetic and Muscular Disorders Research (29 papers), Virus-based gene therapy research (17 papers) and RNA modifications and cancer (10 papers). Kevin D. Foust collaborates with scholars based in United States, United Kingdom and France. Kevin D. Foust's co-authors include Brian K. Kaspar, Curtis M. Chan, Chrystal L. Montgomery, Emily Nurre, Lyndsey Braun, Arthur H.M. Burghes, Adam K. Bevan, Leah Schmelzer, Carlos J. Miranda and Laura Ferraiuolo and has published in prestigious journals such as Nature, Nature Medicine and Neuron.

In The Last Decade

Kevin D. Foust

47 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes

2008 1.1k citations Kevin D. Foust, Emily Nurre et al. Nature Biotechnology profile →
Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

2011 611 citations Amanda Haidet-Phillips, Carlos J. Miranda et al. Nature Biotechnology profile →
Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis

2014 508 citations Laura Ferraiuolo, Amanda Haidet-Phillips et al. Neuron profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin D. Foust United States	31	3.0k	1.8k	1.7k	1.2k	825	47	5.4k
Nicholas D. Mazarakis United Kingdom	36	2.5k 0.8×	1.3k 0.7×	675 0.4×	883 0.7×	1.0k 1.2×	63	4.2k
Cathleen Lutz United States	33	2.8k 0.9×	566 0.3×	1.3k 0.8×	861 0.7×	1.1k 1.4×	82	4.3k
Frank Rigo United States	48	8.6k 2.9×	1.1k 0.6×	3.8k 2.3×	2.2k 1.8×	1.6k 1.9×	141	11.2k
Mimoun Azzouz United Kingdom	31	2.2k 0.7×	827 0.5×	1.3k 0.8×	1.3k 1.1×	956 1.2×	77	3.8k
John Forsayeth United States	51	3.6k 1.2×	1.8k 1.0×	535 0.3×	1.2k 1.0×	2.7k 3.3×	118	6.6k
Derek J. Blake United Kingdom	48	6.2k 2.1×	1.2k 0.7×	596 0.4×	723 0.6×	2.3k 2.8×	98	8.4k
Steven J. Gray United States	38	3.6k 1.2×	2.9k 1.6×	555 0.3×	309 0.3×	913 1.1×	110	5.6k
Imaharu Nakano Japan	44	2.6k 0.9×	634 0.3×	1.2k 0.7×	3.7k 3.0×	2.1k 2.6×	238	7.0k
Miguel Sena‐Esteves United States	46	4.0k 1.3×	2.7k 1.5×	488 0.3×	529 0.4×	1.1k 1.3×	151	6.6k
Brian K. Kaspar United States	54	7.3k 2.4×	3.3k 1.8×	3.2k 1.9×	2.9k 2.4×	2.6k 3.1×	122	12.4k

Countries citing papers authored by Kevin D. Foust

Since Specialization

Citations

This map shows the geographic impact of Kevin D. Foust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin D. Foust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin D. Foust more than expected).

Fields of papers citing papers by Kevin D. Foust

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin D. Foust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin D. Foust. The network helps show where Kevin D. Foust may publish in the future.

Co-authorship network of co-authors of Kevin D. Foust

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin D. Foust. A scholar is included among the top collaborators of Kevin D. Foust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin D. Foust. Kevin D. Foust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Powers, Samantha K., Carlos J. Miranda, Lyndsey Braun, et al.. (2019). Rett syndrome gene therapy improves survival and ameliorates behavioral phenotypes in MeCP2 null (S51.002). Neurology. 92(15_supplement). 5 indexed citations

Thomsen, Gretchen M., Ching-Chyuan Hsieh, Steven M. Solano, et al.. (2019). O.24Biodistribution of onasemnogene abeparvovec (AVXS-101) DNA, mRNA, and SMN protein in human tissue. Neuromuscular Disorders. 29. S122–S123. 2 indexed citations

Alfano, Lindsay N., Linda Lowes, Samiah Al-Zaidy, et al.. (2018). AVXS-101 Phase 1 Gene Replacement Therapy Clinical Trial in SMA Type 1: Patients Treated Early with the Proposed Therapeutic Dose Were Able to Sit Unassisted at a Younger Age (S29.002). Neurology. 90(15_supplement). 1 indexed citations

Gombash, Sara E., Christopher Cowley, Julie C. Fitzgerald, et al.. (2017). Systemic gene delivery transduces the enteric nervous system of guinea pigs and cynomolgus macaques. Gene Therapy. 24(10). 640–648. 18 indexed citations

Bosch, Megan E., Amy L. Aldrich, Rachel W. Fallet, et al.. (2016). Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3). Journal of Neuroscience. 36(37). 9669–9682. 49 indexed citations

Iyer, Chitra C., Vicki L. McGovern, Jason D. Murray, et al.. (2015). Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA. Human Molecular Genetics. 24(21). 6160–6173. 32 indexed citations

Gombash, Sara E., Christopher Cowley, Julie C. Fitzgerald, et al.. (2015). SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice. Human Molecular Genetics. 24(13). 3847–3860. 42 indexed citations

Gombash, Sara E. & Kevin D. Foust. (2015). Systemic Gene Therapy for Targeting the CNS. Methods in molecular biology. 1382. 231–237. 1 indexed citations

McGovern, Vicki L., Chitra C. Iyer, W. David Arnold, et al.. (2015). SMN expression is required in motor neurons to rescue electrophysiological deficits in the SMNΔ7 mouse model of SMA. Human Molecular Genetics. 24(19). 5524–5541. 47 indexed citations

10.

O’Reilly, Mary, Wendy Oakden, Margarete K. Akens, et al.. (2015). Gene delivery to the spinal cord using MRI-guided focused ultrasound. Gene Therapy. 22(7). 568–577. 69 indexed citations

11.

Gombash, Sara E., Christopher Cowley, Julie C. Fitzgerald, et al.. (2014). Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice. Frontiers in Molecular Neuroscience. 7. 81–81. 43 indexed citations

12.

Ferraiuolo, Laura, Amanda Haidet-Phillips, Leah Schmelzer, et al.. (2014). Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis. Neuron. 81(5). 1009–1023. 508 indexed citations breakdown →

13.

Foust, Kevin D., Desirée L. Salazar, Shibi Likhite, et al.. (2013). Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS. Molecular Therapy. 21(12). 2148–2159. 160 indexed citations

14.

Jordão, Jessica F., Meaghan A. O’Reilly, Kelly A. Markham, et al.. (2012). Targeted Delivery of Self-Complementary Adeno-Associated Virus Serotype 9 to the Brain, Using Magnetic Resonance Imaging-Guided Focused Ultrasound. Human Gene Therapy. 23(11). 1144–1155. 165 indexed citations

15.

Bevan, Adam K., Sandra Duqué, Kevin D. Foust, et al.. (2011). Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders. Molecular Therapy. 19(11). 1971–1980. 256 indexed citations

16.

Porensky, Paul, Chalermchai Mitrpant, Vicki L. McGovern, et al.. (2011). A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Human Molecular Genetics. 21(7). 1625–1638. 209 indexed citations

17.

Bevan, Adam K., Kirk R. Hutchinson, Kevin D. Foust, et al.. (2010). Early heart failure in the SMNΔ7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Human Molecular Genetics. 19(20). 3895–3905. 170 indexed citations

18.

Manfredsson, Fredric P., Nihal Tümer, Benedek Erdős, et al.. (2009). Nigrostriatal rAAV-mediated GDNF Overexpression Induces Robust Weight Loss in a Rat Model of Age-related Obesity. Molecular Therapy. 17(6). 980–991. 83 indexed citations

19.

Foust, Kevin D., et al.. (2008). Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nature Biotechnology. 27(1). 59–65. 1060 indexed citations breakdown →

20.

McLaughlin, Thomas, Travis Cossette, Qiushi Tang, et al.. (2008). Recombinant AAV Serotype and Capsid Mutant Comparison for Pulmonary Gene Transfer of α-1-Antitrypsin Using Invasive and Noninvasive Delivery. Molecular Therapy. 17(1). 81–87. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact